Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins
about
Fusion protein comprised of the two schistosomal antigens, Sm14 and Sm29, provides significant protection against Schistosoma mansoni in murine infection modelThe totality-of-the-evidence approach to the development and assessment of GP2015, a proposed etanercept biosimilar.Feeding strategies enhance high cell density cultivation and protein expression in milliliter scale bioreactors.Optimizing assembly and production of native bispecific antibodies by codon de-optimization.Large-scale purification and characterization of recombinant human stem cell factor in Escherichia coli.
P2860
Biotechnology and genetic engineering in the new drug development. Part I. DNA technology and recombinant proteins
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Biotechnology and genetic engi ...... ology and recombinant proteins
@ast
Biotechnology and genetic engi ...... ology and recombinant proteins
@en
Biotechnology and genetic engi ...... ology and recombinant proteins
@nl
type
label
Biotechnology and genetic engi ...... ology and recombinant proteins
@ast
Biotechnology and genetic engi ...... ology and recombinant proteins
@en
Biotechnology and genetic engi ...... ology and recombinant proteins
@nl
prefLabel
Biotechnology and genetic engi ...... ology and recombinant proteins
@ast
Biotechnology and genetic engi ...... ology and recombinant proteins
@en
Biotechnology and genetic engi ...... ology and recombinant proteins
@nl
P2093
P1476
Biotechnology and genetic engi ...... ology and recombinant proteins
@en
P2093
Librowski T
Lochyński S
Stryjewska A
P304
P356
10.1016/S1734-1140(13)71466-X
P407
P577
2013-01-01T00:00:00Z